OBJECTIVES: To evaluate c-erbB-2 gene amplification and its prognostic significance in transitional cell carcinoma of the bladder. METHODS: Alterations in the gene copy number of c-erbB-2 were detected in 57 bladder tumor samples using a method based on the polymerase chain reaction. RESULTS: Eighteen tumors (32%) showed gene amplification of c-erbB-2, which correlated with tumor grade and stage. A strong association of c-erbB-2 amplification with patient survival was also found. The amplification resulted in a significantly poorer prognosis among the patients with high-grade and/or invasive tumors. Multivariate analysis revealed that c-erbB-2 amplification and tumor grade were independent prognostic factors. CONCLUSIONS: Our data indicate a possible role of the c-erbB-2 gene in the development of aggressive behavior in bladder tumors. Moreover, the use of c-erbB-2 gene amplification, together with tumor grade and stage, could provide an accurate basis for determining the prognosis of bladder cancer.
OBJECTIVES: To evaluate c-erbB-2 gene amplification and its prognostic significance in transitional cell carcinoma of the bladder. METHODS: Alterations in the gene copy number of c-erbB-2 were detected in 57 bladder tumor samples using a method based on the polymerase chain reaction. RESULTS: Eighteen tumors (32%) showed gene amplification of c-erbB-2, which correlated with tumor grade and stage. A strong association of c-erbB-2 amplification with patient survival was also found. The amplification resulted in a significantly poorer prognosis among the patients with high-grade and/or invasive tumors. Multivariate analysis revealed that c-erbB-2 amplification and tumor grade were independent prognostic factors. CONCLUSIONS: Our data indicate a possible role of the c-erbB-2 gene in the development of aggressive behavior in bladder tumors. Moreover, the use of c-erbB-2 gene amplification, together with tumor grade and stage, could provide an accurate basis for determining the prognosis of bladder cancer.
Authors: Andrea Slusser-Nore; Scott H Garrett; Xu Dong Zhou; Donald A Sens; Mary Ann Sens; Seema Somji Journal: Toxicol Appl Pharmacol Date: 2017-05-10 Impact factor: 4.219
Authors: M Gallucci; F Guadagni; R Marzano; C Leonardo; R Merola; S Sentinelli; E M Ruggeri; R Cantiani; I Sperduti; F de la Iglesia Lopez; A M Cianciulli Journal: J Clin Pathol Date: 2005-04 Impact factor: 3.411
Authors: Surendra B Kolla; Amlesh Seth; Manoj K Singh; Narmada P Gupta; Ashok K Hemal; Prem N Dogra; Rajeev Kumar Journal: Int Urol Nephrol Date: 2008 Impact factor: 2.370
Authors: Wassim Kassouf; Peter C Black; Tomasz Tuziak; Jolanta Bondaruk; Sangkyou Lee; Gordon A Brown; Liana Adam; Caimiao Wei; Keith Baggerly; Menashe Bar-Eli; David McConkey; Bogdan Czerniak; Colin P Dinney Journal: J Urol Date: 2007-11-19 Impact factor: 7.450
Authors: Matthew D Galsky; Tal Zaks; Habib Hassani; Linda Vocila; Guru Sonpavde; Thomas E Hutson; Daniel D Von Hoff Journal: Invest New Drugs Date: 2009-03-06 Impact factor: 3.850